Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy centerDove Medical PressBackground: Many placebo-controlled studies have demonstrated that allergen immunotherapy (AIT) is an effective therapy for treating aller… Continue reading
CBS News |
Medical innovations to watch for in 2017
CBS News CRISPR. At the top of Agus’ list is a much-discussed gene editing biotechnology called CRISPR, derived from a bacterial protein, that lets scientists clip away or tweak specific portions of DNA. “We saw the rise this year, over and over again, of the … |
Immuno-Oncology News |
CAR-T Immunotherapy Shows Promise in Aggressive Brain Cancers, Case Study Reports
Immuno-Oncology News Immunotherapy using genetically modified immune T-cells (CAR-T) to specifically target the glioma-associated marker IL13Rα2 — a gene expression indicative of an aggressive brain tumor — was reported to be a successful treatment for recurrent … |
The Rockefeller University Newswire |
Scientists learn how to ramp up microbes’ ability to make memories
The Rockefeller University Newswire “CRISPR, the adaptive immune system found within many bacteria, remembers viruses by storing snippets of their DNA. But in nature, these recording events happen only rarely,” says senior author Luciano Marraffini, head of the Laboratory of Bacteriology. |
I4U News |
Monsanto Licenses CRISPR/Cpf1 From Broad Institute
GenomeWeb NEW YORK (GenomeWeb) – Agricultural giant Monsanto has licensed CRISPR/Cpf1 genome editing technology from the Broad Institute. Under the terms of the agreement, Monsanto gains worldwide, non-exclusive rights to agricultural applications of the … Monsanto (MON) Enters Global Genome-Editing Licensing Agreement for CRISPR SystemStreetInsider.com Off-Switch Discovered for CRISPR-Cas9 Gene Editing Tool – I4U NewsI4U News Altered Genes | The Straight Dope | Salt Lake City | Salt Lake City …Salt Lake City Weekly Pc-Tablet Media –States Chronicle all 7 news articles » |
|
Immunotherapy, gene therapy combination shows promise against glioblastoma
Science Daily “We hope the implementation of our gene therapy strategy for gliomas, used in combination with immune checkpoint blockade, will eventually provide successful treatment for patients with this devastating brain cancer,” says Maria Castro, Ph.D., co … |
Genetic Literacy Project |
Excitement for mitochondrial gene therapy hides technique’s unexpected risks
Genetic Literacy Project [A] study published…by Shoukhrat Mitalipov, head of the Center for Embryonic Cell and Gene Therapy at the Oregon Health and Science University in Portland, suggested that in roughly 15 percent of cases, the mitochondrial replacement could fail and … Three-parent baby treatment comes with severe health risks, according to new researchThe Christian Times |